ASP: Brovana sees another increase
BALTIMORE – Payment increased for brand-name drug Brovana (J7605) in the third quarter of 2014 to $6.39 per dose, up 25 cents from the previous quarter, according to average sales price (ASP) figures released June 17. By contrast, Perforomist (J7606) saw payment decrease 29 cents to $6.62 per dose. Payment for budesonide (J7626) decreased 20 cents to $4.90 per dose. Payment for albuterol (J7613) stayed relatively flat at just over 13 cents per dose, and payment for ipratropium (J7644) was unchanged at just under 12 cents per dose.